Cannabidiolic acid (CBDA) is a CBD precursor found in the fiber and seed oil hemp plant. Its health benefits have been overshadowed by the scientific attention paid to CBD. CBDA binds to different receptors than CBD and inhibits enzymes that affect the endocannabinoid system (ECS). Emerging research suggests that CBDA may:
Relieve nausea and vomiting (especially after chemotherapy)
Affects serotonin levels (affects sleep, mood, and appetite)
CBDA is being investigated for its potential as an anti-inflammatory, antiemetic poland telegram , anticonvulsant, and anticancer agent. Efforts to develop reliable purification methods have been limited. Ongoing studies are exploring whether CBDA may have anti-inflammatory properties similar to those of NSAIDs.
THC
THCVA (tetrahydrocannabinolic acid) is a precursor to THCV (tetrahydrocannabidiol). It has similarities to other cannabinoids extracted from raw cannabis flowers. Early research suggests that THCVA can relieve pain and reduce inflammation.
Research suggests that THCV may also help reduce overeating and obesity, offering potential benefits for weight management. THCV is currently being studied for its potential to alleviate symptoms of post-traumatic stress disorder (PTSD), degenerative neurological diseases such as Alzheimer’s, and mental health issues such as depression and anxiety.